| PERIOD ENDING | 31-Jan-09 | 31-Jul-08 | 30-Apr-08 | 31-Jan-08 | | Total Revenue |
-
| 249 | 301 |
-
| | Cost of Revenue | 13 | 10 | 15 |
-
| | | Gross Profit | (13) | 239 | 287 |
-
| | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 616 | 697 | 696 | 736 | | Non Recurring | 726 | 815 | 1,034 |
-
| | Others | 10 | 61 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,364) | (1,335) | (1,444) | (736) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 0 | 2 | (361) | 2 | | Earnings Before Interest And Taxes | (1,364) | (1,333) | (1,804) | (734) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,364) | (1,333) | (1,804) | (734) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,364) | (1,333) | (1,804) | (734) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,364) | (1,333) | (1,804) | (734) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,364) | ($1,333) | ($1,804) | ($734) |
|
0.02% Nasdaq 
0.33%
Income Statement
